Menu Close

Articles on Doha Declaration

Displaying all articles

Drug patents don’t necessarily spur companies to innovate so much as restrict access to their IP. Andrii Zastrozhnov/iStock via Getty Images Plus

Pharma’s expensive gaming of the drug patent system is successfully countered by the Medicines Patent Pool, which increases global access and rewards innovation

The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
The WTO negotiations have been plagued with irreconcilable differences from the start. Made Nagi/AAP

WTO struggles across the line in new era of policy malaise

The WTO Multilateral Trade Negotiations in Bali almost failed. By negotiating for one day beyond the scheduled conference time, 159 exhausted nations finally concluded an agreement. What’s at stake are…
Drug prices reduce dramatically when large multinationals’ monopoly is broken. m.p.3./Flickr

Big Pharma in legal battles for monopoly prices in India

Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s…

Top contributors

More